Tag Archives: TRCB

Top 10 Value Stocks For 2019

The cryptocurrency market continued its hot streak on Tuesday, with most major currencies up more than 5 percent. Here’s a look at some of the headlines that were moving the cryptocurrency market today and which currencies were on the move.

Headlines

A new Thompson Reuters survey found that one out of five financial firms are currently considering trading cryptocurrencies within the next year. Banks, hedge funds and other financial institutions have mostly shied away from cryptocurrency trading up to this point, but an increase in interest could go a long way in making cryptos mainstream.

Blue Line Futures president Bill Baruch, who called a bitcoin rally when the currency was trading at around $7,200 back in February, now says the current rally has more room to run. Baruch said bitcoin’s resiliency in the face of ongoing regulatory threats is a bullish sign, and a breach of the $10,000 level would likely send the price to $11,500.

With bitcoin prices now at their highest levels since March at above $9,200, former Intuit Inc. (NASDAQ: INTU) and Paypal Holdings Inc (NASDAQ: PYPL) CEO Bill Harris wrote an op-ed piece for Recode in which he called bitcoin “the greatest scam in history.” Harris said cryptocurrencies are massive pump-and-dump schemes and fraud artists are taking advantage of cryptocurrency investors naivety and greed. He added that bitcoin has no intrinsic value, isn't an effective store of value and isn't accepted by the vast majority of businesses, making it virtually useless as a means of payment.

Top 10 Value Stocks For 2019: Calavo Growers, Inc.(CVGW)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap avocado and fresh food stock Calavo Growers (NASDAQ: CVGW) has elevated short interest of 33.51% according to Highshortinterest.com. Founded in 1924, Calavo Growers is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The Companys Fresh segment procures and markets fresh avocados and select other fresh produce (tomatoes) while the Renaissance Food Group segment (RFG) creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Calavo Growers (CVGW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Prudential Financial Inc. raised its holdings in shares of Calavo Growers (NASDAQ:CVGW) by 5.9% during the first quarter, HoldingsChannel.com reports. The firm owned 28,216 shares of the company’s stock after acquiring an additional 1,580 shares during the quarter. Prudential Financial Inc.’s holdings in Calavo Growers were worth $2,602,000 at the end of the most recent quarter.

  • [By Asit Sharma]

    Calavo Growers, Inc. (NASDAQ:CVGW), which I’ve dubbed a “tiny, mighty dividend stock,” reported fiscal second-quarter 2018 earnings on June 6. How has this dynamic avocado market specialist fared so far in its fiscal year? Let’s dive into the quarter’s detailsafter first walking through headline numbers directly below.

Top 10 Value Stocks For 2019: America First Tax Exempt Investors L.P.(ATAX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of America First Tax Exempt Investors, L.P. (NASDAQ:ATAX) hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $6.47 and last traded at $6.43, with a volume of 54800 shares changing hands. The stock had previously closed at $6.43.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on America First Multifamily Investors (ATAX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks For 2019: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
    Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
    The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
    Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
    Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
    LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
    Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
    TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
    The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
    A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
    Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
    Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
    ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
    KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13

  • [By Tyler Crowe, Matthew DiLallo, and Reuben Gregg Brewer]

    Fortunately for those looking at these attractive valuations, oil’s end-of-days scenario is likely a ways down the road. So we asked three Fool.com contributors to highlight a stock they see in the oil industry right now that looks attractive. Here’s why they picked Plains All American Pipeline (NYSE:PAA), Marathon Petroleum (NYSE:MPC), and Magellan Midstream Partners (NYSE:MMP).

  • [By Matthew DiLallo]

    There’s just one problem with all that production: It needs to get out of the basin, which is a problem right now sincethere aren’t enough pipelines. Because of that, some of the best ways to play the Permian production boom are pipeline companies. Three perfectly positioned to profit from the Permian boom arePlains All American Pipeline(NYSE:PAA),Targa Resources(NYSE:TRGP), andKinder Morgan(NYSE:KMI).

  • [By Joseph Griffin]

    Shares of Plains All American Pipeline, L.P. (NYSE:PAA) have earned an average rating of “Hold” from the twenty-four brokerages that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $25.94.

  • [By John Bromels]

    That’s what happened to U.S. oil and gas pipeline operatorsKinder Morgan, Inc.(NYSE:KMI) and master limited partnership(MLP)Plains All American Pipeline(NYSE:PAA) in 2016. Both made a major dividend/distribution cut. Both stocks took a hit. And neither one has recovered: Plains All American is down 53.3% over the last three years, while Kinder Morgan is down a painful 63.1%.

Top 10 Value Stocks For 2019: Limelight Networks Inc.(LLNW)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Limelight Networks Inc.(NASDAQ:LLNW) jumped 25.5% in April, according to data fromS&P Global Market Intelligence, after the digital content-delivery specialist announced significantly stronger-than-expected first-quarter results.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Limelight Networks (LLNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    (Nasdaq: CNET)

    $2.95 34.76%
    Seadrill Ltd. (NYSE: SDRL) $0.28 33.81%
    Intelsat Corp. (NYSE: I) $9.11 31.50%
    Navios Maritime Midstream Partners LP (NYE: NAP) $4.42 29.18%
    Limelight Networks Inc. (Nasdaq: LLNW) $4.89 28.61%
    Enphase Energy Inc. (Nasdaq: ENPH) $5.05 24.62%

    As you can see in the table above, penny stocks have the potential to provide tremendous returns for enterprising investors. However, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Lisa Levin]

    Shares of Limelight Networks, Inc. (NASDAQ: LLNW) got a boost, shooting up 26 percent to $5.17 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.

  • [By Anders Bylund]

    Content delivery veteran Limelight Networks (NASDAQ:LLNW) reported first-quarter results this Thursday evening, and it was a humdinger. The company, which helps other businesses deliver digital data such as file downloads and video streams in a more efficient manner, crushed Wall Street’s consensus estimates and raised its full-year guidance targets.

Top 10 Value Stocks For 2019: Madrigal Pharmaceuticals, Inc. (MDGL)

Advisors’ Opinion:

  • [By Keith Speights]

    Last week, Viking stock soared over 80% because of great clinical results from another biotech — Madrigal Pharmaceuticals (NASDAQ:MDGL). Why such a big sympathy move for Viking? Madrigal reported positive phase 2 results for its lead candidate MGL-3196 in treating non-alcoholic steatohepatitis (NASH), a serious non-alcoholic fatty liver disease. MGL-3196, like VK2809, isa thyroid hormone receptor beta-selective agonist. Madrigal’s results could bode well for VK2809’s chances.

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Averagetaking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

  • [By Lisa Levin]

    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares shot up 144 percent to $264.885 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.

  • [By Sean Williams]

    Perhaps no company has received more interest in recent weeks than Madrigal Pharmaceuticals (NASDAQ:MDGL) which, might I add, has gained more than 1,800% over the trailing year.

  • [By Lisa Levin]

    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares shot up 127 percent to $245.98 in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.

  • [By Keith Speights]

    Withsuch a huge amount of money on the line, quite a few drugmakers are developing NASH drugs. We’ll probably soon see acquisitions activity heat up. I think Madrigal Pharmaceuticals (NASDAQ:MDGL) and Viking Therapeutics (NASDAQ:VKTX) are highly likely to be gobbled up in the not-too-distant future. My hunch is that Bristol-Myers Squibb (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), and Pfizer (NYSE:PFE) could be among the potential buyers.

Top 10 Value Stocks For 2019: New Relic, Inc.(NEWR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    New Relic (NYSE:NEWR) has received an average recommendation of “Buy” from the sixteen brokerages that are covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $65.38.

  • [By Max Byerly]

    New Relic Inc (NYSE:NEWR) CRO Erica Schultz sold 1,800 shares of the stock in a transaction that occurred on Friday, June 15th. The stock was sold at an average price of $108.40, for a total value of $195,120.00. Following the completion of the transaction, the executive now owns 21,157 shares in the company, valued at approximately $2,293,418.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

  • [By Ethan Ryder]

    New Relic (NYSE:NEWR) had its target price increased by BMO Capital Markets from $95.00 to $110.00 in a report published on Tuesday, Marketbeat reports. BMO Capital Markets currently has an outperform rating on the software maker’s stock.

Top 10 Value Stocks For 2019: Omeros Corporation(OMER)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
  • [By Joseph Griffin]

    BidaskClub upgraded shares of Omeros (NASDAQ:OMER) from a sell rating to a hold rating in a research report report published on Wednesday morning.

    Several other research firms also recently issued reports on OMER. HC Wainwright set a $30.00 price objective on shares of Omeros and gave the stock a buy rating in a report on Tuesday, January 23rd. Maxim Group set a $24.00 price objective on shares of Omeros and gave the stock a buy rating in a report on Monday, January 22nd. ValuEngine upgraded shares of Omeros from a sell rating to a hold rating in a report on Friday, February 2nd. Wedbush downgraded shares of Omeros from an outperform rating to a neutral rating and dropped their price objective for the stock from $47.00 to $19.00 in a report on Friday, March 23rd. Finally, WBB Securities restated a buy rating and set a $75.00 price objective on shares of Omeros in a report on Monday, March 26th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The company has an average rating of Hold and a consensus target price of $25.88.

  • [By Dan Caplinger]

    Wall Street had a good day on Wednesday, as the Dow Jones Industrial Average and other widely followed stock market indexes generally closed modestly higher. Good news from the long-struggling big-box retail sector helped make investors more enthusiastic about the U.S. economy’s prospects, distracting from worries about macroeconomic and geopolitical tensions. Yet some stocks had challenges they couldn’t overcome, and Omeros (NASDAQ:OMER), Party City Holdco (NYSE:PRTY), and Overstock.com (NASDAQ:OSTK) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    ValuEngine downgraded shares of Omeros (NASDAQ:OMER) from a buy rating to a hold rating in a report issued on Wednesday morning.

    Several other research analysts also recently commented on OMER. Zacks Investment Research raised shares of Omeros from a sell rating to a hold rating in a research note on Wednesday. HC Wainwright set a $34.00 price target on shares of Omeros and gave the stock a buy rating in a research note on Thursday, May 3rd. BidaskClub raised shares of Omeros from a sell rating to a hold rating in a research note on Wednesday, May 9th. Maxim Group set a $25.00 target price on shares of Omeros and gave the stock a buy rating in a research note on Sunday, May 13th. Finally, Wedbush reaffirmed a hold rating and issued a $20.00 target price (up from $19.00) on shares of Omeros in a research note on Wednesday, May 16th. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Omeros currently has a consensus rating of Hold and an average price target of $26.00.

  • [By Chris Lange]

    Omeros Corp. (NASDAQ: OMER) is expected to release data from its Phase 2 study of OMS721/IgAN in patients not taking steroids (U.S. cohort). Shares of Omeros closed Friday at $18.14. The consensus analyst target is $36.40, and the 52-week range is $8.36 to $25.20.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Omeros (OMER)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks For 2019: Curtiss-Wright Corporation(CW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Curtiss-Wright (NYSE:CW) declared a quarterly dividend on Wednesday, May 16th, RTT News reports. Shareholders of record on Thursday, June 21st will be paid a dividend of 0.15 per share by the aerospace company on Thursday, July 5th. This represents a $0.60 annualized dividend and a yield of 0.46%.

  • [By Max Byerly]

    Dynamic Technology Lab Private Ltd decreased its stake in shares of Curtiss-Wright Corp. (NYSE:CW) by 59.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,188 shares of the aerospace company’s stock after selling 4,625 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Curtiss-Wright were worth $430,000 at the end of the most recent quarter.

Top 10 Value Stocks For 2019: Two River Bancorp(TRCB)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Two Rivers Bancorp (NASDAQ:TRCB) have trended somewhat positive recently, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Two Rivers Bancorp earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.3815117771449 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Top 10 Value Stocks For 2019: Church & Dwight Company, Inc.(CHD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Church & Dwight (NYSE: CHD) and Unilever (NYSE:UL) are both large-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By Shane Hupp]

    Church & Dwight (NYSE:CHD) was the target of some unusual options trading on Thursday. Traders bought 1,177 call options on the company. This is an increase of approximately 1,010% compared to the typical volume of 106 call options.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Church & Dwight (CHD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BNP Paribas Arbitrage SA lowered its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 5.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 137,607 shares of the company’s stock after selling 7,557 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Church & Dwight were worth $6,930,000 at the end of the most recent reporting period.

  • [By Shane Hupp]

    Church & Dwight (NYSE:CHD)‘s stock had its “buy” rating reissued by research analysts at Jefferies Financial Group in a report issued on Sunday. They presently have a $55.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 14.13% from the company’s previous close.

  • [By Ethan Ryder]

    Church & Dwight (NYSE:CHD) was the recipient of a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 13,509,412 shares, a growth of 25.9% from the April 13th total of 10,734,473 shares. Based on an average daily volume of 2,175,548 shares, the days-to-cover ratio is presently 6.2 days. Approximately 5.6% of the shares of the stock are sold short.